ArticleCancers2021

The Pseudokinase TRIB3 Negatively Regulates the HER2 Receptor Pathway and Is a Biomarker of Good Prognosis in Luminal Breast Cancer.

Alba Orea-Soufi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.